Google DeepMind has undergone a dramatic cultural shift since merging with Google Brain in 2023, adopting startup-like speed and agility while wielding the compute resources of one of the world's largest technology companies. Demis Hassabis, the organization's leader, described this transformation as essential to competing in what he calls a "ferocious" competitive environment where even 20 and 30-year veterans say they've never experienced such intensity .

Why Did Google DeepMind Need to Reinvent Itself?

The 2023 merger of DeepMind and Google Brain created a powerful research organization on paper, but it initially lacked the operational speed needed to move quickly in today's AI landscape. Hassabis explained that the organization had to "come back to almost our startup or entrepreneurial roots and be scrappier, be faster, ship things really quickly" . This wasn't just about reorganizing teams; it required a fundamental cultural reset.

Hassabis

The transformation involved three key elements. First, the organization aligned talent from across Google, pushing everyone in one unified direction. Second, DeepMind gained access to Google's massive compute infrastructure, which it had previously lacked at scale. Third, and perhaps most importantly, the organization adopted what Hassabis called "relentless sort of focus and pace" . This combination of resources and mentality has proven effective; Gemini, Google's flagship AI assistant, reached approximately 750 million monthly active users by the end of 2025 .

How Is Google DeepMind Accelerating Its Product Release Cycle?

One of the most visible results of this startup mentality is a dramatically accelerated product release schedule. Google's open-weight model program, which includes recent releases like Gemma 4, now operates from the same research and training infrastructure as Gemini 3, closing a gap that previously existed between frontier research and open-source contributions . This means cutting-edge research is reaching developers and researchers faster than ever before.

The speed of these releases has not gone unnoticed by competitors. When Gemini 3 launched in November 2025, it prompted what secondary reporting described as an "urgent internal response" at OpenAI, signaling that Google's pace is reshaping competitive dynamics across the industry .

Steps to Understanding Google DeepMind's Competitive Positioning

• Capital Commitment: Alphabet spent $91.4 billion on capital expenditure in 2025 and has guided for between $175 billion and $185 billion in 2026, nearly doubling investment to support compute infrastructure and custom chip partnerships with companies like Broadcom .
• Leadership Alignment: Hassabis speaks with Sundar Pichai, Alphabet's chief executive, every day, reflecting how deeply Google DeepMind now operates at the operational center of Alphabet's product and research strategy .
• Foundational Research Legacy: Hassabis claims that approximately 90 percent of the breakthroughs underpinning the modern AI industry were produced by either Google Brain, Google Research, or DeepMind, including the transformer architecture from 2017 and deep reinforcement learning techniques .

"The most intense environment they've ever seen, perhaps ever in the technology industry," said Demis Hassabis, describing what veteran employees with 20 and 30-year careers are experiencing at Google DeepMind.

Demis Hassabis, CEO of Google DeepMind

What About Hassabis's Other Major Project?

Beyond leading Google DeepMind, Hassabis also runs Isomorphic Labs, the pharmaceutical AI spinoff that DeepMind established in 2021. His commitment to this dual role is extraordinary; he described working a "second workday" beginning around 10pm dedicated to Isomorphic's drug discovery program . This reflects his conviction that applying AI to drug discovery is both his most important long-term ambition and a project requiring sustained personal involvement.

Isomorphic Labs raised $600 million in April 2025 and has partnership agreements with pharmaceutical giants Eli Lilly and Novartis with combined milestone values of up to $3 billion . In February 2026, the company released IsoDDE, a drug design tool that Isomorphic says doubles the accuracy of AlphaFold 3 for generating drug candidates. Human clinical trials in oncology are expected later in 2026 .

The competitive dynamics in AI-driven drug discovery are intensifying across the industry. Anthropic's acquisition of Coefficient Bio for approximately $400 million in April 2026, a stealth startup founded by former Genentech computational biology researchers, signals that general-purpose AI companies are now treating pharmaceutical discovery as a product category, not merely a demonstration of model capability .

Can This Startup Model Sustain Google's Advantage?

Hassabis's strategy of bringing startup speed inside the resource base of a massive technology company represents a deliberate attempt to create a durable competitive advantage. However, the scale of capital flowing into the AI field is making that advantage harder to sustain. SoftBank's $40 billion bridge loan to OpenAI represents a form of capitalization that even Alphabet's compute commitments cannot trivially match in kind .

The competitive environment Hassabis describes is not rhetorical; it is a structural reality of a race in which the resources of incumbents and the ambitions of challengers have converged to a point where institutional inertia is not merely a disadvantage but a disqualifying one. The startup mentality he describes at Google DeepMind is, in that context, a necessity rather than a preference. For an organization with the resources of Alphabet, moving at startup speed is no longer optional; it is the price of remaining competitive in an industry where the pace of innovation has become the primary determinant of market position .